|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00660 WAI CHUN BIOTEC
Nominal 
0.115 0.000 (0.000%) | 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 161,056 | -15.381% | 370,069 | 773,654 | 1,007,186 | 567,553 |
| Cost of Sales | (139,926) | -19.367% | (335,888) | (723,241) | (917,001) | (518,623) |
| Gross Profit | 21,130 | 25.811% | 34,181 | 50,413 | 90,185 | 48,930 |
| 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (58,149) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (11,202) | 293.743% | (78,167) | (5,698) | 3,777 | 1,611 | |
| Taxation | (1,852) | 56.287% | 12,460 | (4,364) | (5,167) | (616) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (607) | -77.552% | 21,495 | (5,371) | (20,155) | (9,144) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (13,661) | 102.866% | (44,212) | (15,433) | (21,545) | (8,149) | |
| 2024/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 10,373 | 17.488% | 17,897 | 17,076 | 20,924 | 7,889 |
| Depreciation & Amortisation | 8,151 | 44.265% | 11,359 | 14,062 | 16,198 | 6,375 |
| Directors' Emoluments | -- | -- | -- | 1,549 | 4,737 | 2,760 |
| 2024/12 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2024/12 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2020/12 | |
| EPS (cts) | -7.970 | 102.799% | -25.800 | -9.100 | -12.900 | -4.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | 0.290 | 0.029 | (0.002) |
| NBV per share ($) | (0.543) | -- | (0.462) | (0.204) | (0.224) | (0.226) |
| Remarks: | Real time quote last updated: 04/03/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -13,661,000 |
| %Change | 102.866% |
| EPS / (LPS) | HKD -0.080 |
| NBV Per Share ($) | HKD -0.543 |